EXEL, PFE, ONCE Get FDA Nod, FPRX, ZLAB Team Up, SKLN Soars After Hours

Today's Daily Dose brings you news about FDA approvals of EXEL, Medicure, Pfizer and Spark; collaboration deals of Biogen & Ionis, and Five Prime & Zai Lab; Skyline's purchase of equity stake in a precision diagnostic company and TherapeuticsMD's second attempt to get approval for TX-004HR in the treatment of vulvar and vaginal atrophy in postmenopausal women.

from RTT - Biotech http://ift.tt/2BjOkDN
via IFTTT